Pfizer 2011 Annual Report Download - page 55

Download and view the complete annual report

Please find page 55 of the 2011 Pfizer annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 117

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117

Consolidated Balance Sheets
Pfizer Inc. and Subsidiary Companies
AS OF DECEMBER 31,
(MILLIONS, EXCEPT PREFERRED STOCK ISSUED AND PER COMMON SHARE DATA) 2011 2010
Assets
Cash and cash equivalents $ 3,539 $ 1,735
Short-term investments 23,219 26,277
Accounts receivable, less allowance for doubtful accounts: 2011—$227; 2010—$208 13,608 13,380
Short-term loans 51 467
Inventories 7,769 8,275
Taxes and other current assets 9,441 9,440
Assets of discontinued operations and other assets held for sale 101 1,439
Total current assets 57,728 61,013
Long-term investments and loans 9,457 9,747
Property, plant and equipment, less accumulated depreciation 16,938 18,645
Goodwill 45,067 43,928
Identifiable intangible assets, less accumulated amortization 53,833 57,555
Taxes and other noncurrent assets 4,979 4,126
Total assets $188,002 $195,014
Liabilities and Shareholders’ Equity
Short-term borrowings, including current portion of long-term debt: 2011—$6; 2010—$3,502 $ 4,018 $ 5,603
Accounts payable 3,836 3,994
Dividends payable 1,796 1,601
Income taxes payable 1,013 951
Accrued compensation and related items 2,169 2,080
Other current liabilities 15,237 14,256
Liabilities of discontinued operations —151
Total current liabilities 28,069 28,636
Long-term debt 34,931 38,410
Pension benefit obligations 6,355 6,194
Postretirement benefit obligations 3,344 3,035
Noncurrent deferred tax liabilities 19,597 18,628
Other taxes payable 6,886 6,245
Other noncurrent liabilities 6,199 5,601
Total liabilities 105,381 106,749
Commitments and Contingencies
Preferred stock, without par value, at stated value; 27 shares authorized; issued: 2011—1,112;
2010—1,279 45 52
Common stock, $0.05 par value; 12,000 shares authorized; issued: 2011—8,902; 2010—8,876 445 444
Additional paid-in capital 71,423 70,760
Employee benefit trusts (3) (7)
Treasury stock, shares at cost; 2011—1,327; 2010—864 (31,801) (22,712)
Retained earnings 46,210 42,716
Accumulated other comprehensive loss (4,129) (3,440)
Total Pfizer Inc. shareholders’ equity 82,190 87,813
Equity attributable to noncontrolling interests 431 452
Total shareholders’ equity 82,621 88,265
Total liabilities and shareholders’ equity $188,002 $195,014
See Notes to Consolidated Financial Statements, which are an integral part of these statements.
54 2011 Financial Report